Clinical Trial Update: Artificial Intelligence and Machine Learning to Guide CDK4/6 Inhibitor Rechallenge in Breast Cancer. [Phase 2]

View source ↗

Summary

A Phase 2 trial at UC San Diego is exploring AI/ML-guided rechallenge with CDK4/6 inhibitors for breast cancer, with recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: University of California, San Diego | Conditions: Breast Cancer | Phase 2 | Status: RECRUITING